A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Public ClinicalTrials.gov record NCT02546700. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Chronic Obstructive Pulmonary Disease and a History of Exacerbations
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Phase II, randomized, double-blind, placebo-controlled, parallel-group clinical trial of lebrikizumab in participants with COPD and a history of exacerbations who are treated with inhaled corticosteroid (ICS) and at least one long-acting bronchodilator inhaler medication. This study will be conducted to assess the safety, efficacy, and patient-reported outcome (PRO) measures.
Study identification
- NCT ID
- NCT02546700
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 309 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 17, 2015 (Actual)
- Primary completion
- Nov 25, 2016 (Actual)
- Completion
- Nov 25, 2016 (Actual)
- Last update posted
- Sep 10, 2026
2015 – 2016
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Achieve Clinical Research, LLC | Birmingham | Alabama | 35216 | — |
| California Medical Research Associates, Inc. | Northridge | California | 91324 | — |
| Palmtree Clinical research Inc | Palm Springs | California | 92262 | — |
| Finlay Medical Research | Miami | Florida | 33126 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| Columbus Regional Research Institute | Columbus | Georgia | 31904 | — |
| Southeast Regional Res Group | Savannah | Georgia | 31405 | — |
| Centex Studies | Lake Charles | Louisiana | 70601 | — |
| The Clinical Research Ctr | St Louis | Missouri | 63141 | — |
| Comprehensive Clinical Research Inc. | Berlin | New Jersey | 08009 | — |
| ISA Clinical Research | Jamaica | New York | 11435 | — |
| Gastonia Pharmaceutical Research | Gastonia | North Carolina | 28054 | — |
| Clinical Research Inst. of Southern Oregon, Pc | Medford | Oregon | 97504 | — |
| S. Carolina Pharmaceutical Research | Spartanburg | South Carolina | 29303 | — |
| Baylor College of Medicine; Ben Taub Hospital- Guntupalli | Houston | Texas | 77030 | — |
| Centex Studies | Houston | Texas | 77058 | — |
| Western Washington Medical Group | Everett | Washington | 98208 | — |
| Premier Clinical Research | Spokane | Washington | 99202 | — |
| MultiCare Health Center of Washington | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02546700, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 10, 2026 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02546700 live on ClinicalTrials.gov.